Corbus Pharmaceuticals (CRBP) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-1.9
-1.67
-1.45
-1.22

Details

Expected EPS
-1.25876
Actual EPS
-1.81
Surprise EPS
-0.55
Surprise Percent
+43.79%

Description

Corbus Pharmaceuticals (CRBP) has reported earnings of -1.81 per share for Q3 2026.

0 Comments

Share your thoughts